136 related articles for article (PubMed ID: 26893937)
1. Mesoglycan attenuates VSMC proliferation through activation of AMP-activated protein kinase and mTOR.
Lee KY; Lee DH; Choi HC
Clin Hypertens; 2015; 22():2. PubMed ID: 26893937
[TBL] [Abstract][Full Text] [Related]
2. Activation of AMPK by Telmisartan Decreases Basal and PDGF-stimulated VSMC Proliferation via Inhibiting the mTOR/p70S6K Signaling Axis.
Hwang YJ; Park JH; Cho DH
J Korean Med Sci; 2020 Sep; 35(35):e289. PubMed ID: 32893519
[TBL] [Abstract][Full Text] [Related]
3. Far-Infrared Irradiation Decreases Proliferation in Basal and PDGF-Stimulated VSMCs Through AMPK-Mediated Inhibition of mTOR/p70S6K Signaling Axis.
Hwang YJ; Park JH; Cho DH
J Korean Med Sci; 2023 Oct; 38(41):e335. PubMed ID: 37873631
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone, a PPARĪ³ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.
Osman I; Segar L
Biochem Pharmacol; 2016 Feb; 101():54-70. PubMed ID: 26643070
[TBL] [Abstract][Full Text] [Related]
5. Nifedipine inhibits vascular smooth muscle cell proliferation and reactive oxygen species production through AMP-activated protein kinase signaling pathway.
Sung JY; Choi HC
Vascul Pharmacol; 2012; 56(1-2):1-8. PubMed ID: 21708289
[TBL] [Abstract][Full Text] [Related]
6. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression.
Igata M; Motoshima H; Tsuruzoe K; Kojima K; Matsumura T; Kondo T; Taguchi T; Nakamaru K; Yano M; Kukidome D; Matsumoto K; Toyonaga T; Asano T; Nishikawa T; Araki E
Circ Res; 2005 Oct; 97(8):837-44. PubMed ID: 16151020
[TBL] [Abstract][Full Text] [Related]
7. Zedoarondiol Inhibits Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cells Proliferation via Regulating AMP-Activated Protein Kinase Signaling Pathway.
Mao H; Tao T; Song D; Liu M; Wang X; Liu X; Shi D
Cell Physiol Biochem; 2016; 40(6):1506-1520. PubMed ID: 27997894
[TBL] [Abstract][Full Text] [Related]
8. AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia.
Fairaq A; Shawky NM; Osman I; Pichavaram P; Segar L
Pharmacol Res; 2017 May; 119():289-302. PubMed ID: 28237515
[TBL] [Abstract][Full Text] [Related]
9. Gliclazide, a K
Lee KY; Kim JR; Choi HC
Vascul Pharmacol; 2018 Mar; 102():21-28. PubMed ID: 29337033
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.
Jojima T; Uchida K; Akimoto K; Tomotsune T; Yanagi K; Iijima T; Suzuki K; Kasai K; Aso Y
Atherosclerosis; 2017 Jun; 261():44-51. PubMed ID: 28445811
[TBL] [Abstract][Full Text] [Related]
11. Losartan Inhibits Vascular Smooth Muscle Cell Proliferation through Activation of AMP-Activated Protein Kinase.
Kim JE; Choi HC
Korean J Physiol Pharmacol; 2010 Oct; 14(5):299-304. PubMed ID: 21165328
[TBL] [Abstract][Full Text] [Related]
12. Metformin inhibits intracranial aneurysm formation and progression by regulating vascular smooth muscle cell phenotype switching via the AMPK/ACC pathway.
Li S; Shi Y; Liu P; Song Y; Liu Y; Ying L; Quan K; Yu G; Fan Z; Zhu W
J Neuroinflammation; 2020 Jun; 17(1):191. PubMed ID: 32546267
[TBL] [Abstract][Full Text] [Related]
13. Genistein-induced LKB1-AMPK activation inhibits senescence of VSMC through autophagy induction.
Lee KY; Kim JR; Choi HC
Vascul Pharmacol; 2016 Jun; 81():75-82. PubMed ID: 26924458
[TBL] [Abstract][Full Text] [Related]
14. Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway.
Kim JS; Kim IK; Lee SY; Song BW; Cha MJ; Song H; Choi E; Lim S; Ham O; Jang Y; Hwang KC
Cell Biol Int; 2012 Mar; 36(3):305-10. PubMed ID: 22050182
[TBL] [Abstract][Full Text] [Related]
15. All-
Zhang J; Deng B; Jiang X; Cai M; Liu N; Zhang S; Tan Y; Huang G; Jin W; Liu B; Liu S
Front Pharmacol; 2019; 10():485. PubMed ID: 31143119
[TBL] [Abstract][Full Text] [Related]
16. Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells.
Liang KW; Yin SC; Ting CT; Lin SJ; Hsueh CM; Chen CY; Hsu SL
Eur J Pharmacol; 2008 Aug; 590(1-3):343-54. PubMed ID: 18590725
[TBL] [Abstract][Full Text] [Related]
17. Aspirin-induced AMP-activated protein kinase activation regulates the proliferation of vascular smooth muscle cells from spontaneously hypertensive rats.
Sung JY; Choi HC
Biochem Biophys Res Commun; 2011 May; 408(2):312-7. PubMed ID: 21514281
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of Brazilin on the vascular smooth muscle cell proliferation and migration induced by PDGF-BB.
Guo J; Li L; Wu YJ; Yan Y; Xu XN; Wang SB; Yuan TY; Fang LH; Du GH
Am J Chin Med; 2013; 41(6):1283-96. PubMed ID: 24228601
[TBL] [Abstract][Full Text] [Related]
19. Adenosine monophosphate-activated protein kinase regulates platelet-derived growth factor-BB-induced vascular smooth muscle cell migration.
Iida M; Tanabe K; Matsushima-Nishiwaki R; Kozawa O; Iida H
Arch Biochem Biophys; 2013 Feb; 530(2):83-92. PubMed ID: 23298764
[TBL] [Abstract][Full Text] [Related]
20. Quercetin-Induced AMP-Activated Protein Kinase Activation Attenuates Vasoconstriction Through LKB1-AMPK Signaling Pathway.
Kim SG; Kim JR; Choi HC
J Med Food; 2018 Feb; 21(2):146-153. PubMed ID: 29035613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
